TABLE 2.
Total | ||
---|---|---|
N | (%) | |
Age <40 | 940 | |
Diagnostic | 370 | (39.4) |
Screen | 322 | (34.3) |
Staging/Treatment | 136 | (14.5) |
Other | 112 | (11.9) |
Age 40–49 | 2,655 | |
Diagnostic | 1,026 | (38.6) |
Screen | 924 | (34.8) |
Staging/Treatment | 385 | (14.5) |
Other | 320 | (12.1) |
Age 50–59 | 2,943 | |
Diagnostic | 1,123 | (38.2) |
Screen | 968 | (32.9) |
Staging/Treatment | 483 | (16.4) |
Other | 369 | (12.5) |
Age 60–69 | 1,742 | |
Diagnostic | 756 | (43.4) |
Screen | 501 | (28.8) |
Staging/Treatment | 300 | (17.2) |
Other | 185 | (10.6) |
Age 70–79 | 651 | |
Diagnostic | 321 | (49.3) |
Screen | 116 | (17.8) |
Staging/Treatment | 147 | (22.6) |
Other | 67 | (10.3) |